Skip to Main Content

Paper Details

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer.
Eur Urol
108
2020
Author NameAffiliation
Jeffrey S RossFoundation Medicine, USA Upstate Medical University
Giorgio GandagliaUrological Research Institute (URI), IRCCS Ospedale San Raffaele
Ryan DittamoreDecipher Biosciences Inc.
Yang LiuDecipher Biosciences Inc.
Elai DavicioniDecipher Biosciences Inc.
Alberto BrigantiUrological Research Institute (URI), IRCCS Ospedale San Raffaele, Italy Vita-Salute San Raffaele University
  • 1 - 6

Datasets

Release 1.2